292 related articles for article (PubMed ID: 33936173)
1. Identification of a MicroRNA Signature Associated With Lymph Node Metastasis in Endometrial Endometrioid Cancer.
Fu K; Li Y; Song J; Cai W; Wu W; Ye X; Xu J
Front Genet; 2021; 12():650102. PubMed ID: 33936173
[TBL] [Abstract][Full Text] [Related]
2. A microRNA disease signature associated with lymph node metastasis of lung adenocarcinoma.
Cen SY; Fu KY; Shi Y; Jiang HL; Shou JW; You LK; Han WD; Pan HM; Liu Z
Math Biosci Eng; 2020 Feb; 17(3):2557-2568. PubMed ID: 32233554
[No Abstract] [Full Text] [Related]
3. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
[TBL] [Abstract][Full Text] [Related]
4. The prognostic miR-532-5p-correlated ceRNA-mediated lipid droplet accumulation drives nodal metastasis of cervical cancer.
Shang C; Li Y; He T; Liao Y; Du Q; Wang P; Qiao J; Guo H
J Adv Res; 2022 Mar; 37():169-184. PubMed ID: 35499057
[TBL] [Abstract][Full Text] [Related]
5. Pilot Study to Establish a Novel Five-Gene Biomarker Panel for Predicting Lymph Node Metastasis in Patients With Early Stage Endometrial Cancer.
Huang CY; Liao KW; Chou CH; Shrestha S; Yang CD; Chiew MY; Huang HT; Hong HC; Huang SH; Chang TH; Huang HD
Front Oncol; 2019; 9():1508. PubMed ID: 32039004
[No Abstract] [Full Text] [Related]
6. Integrated microRNA, gene expression and transcription factors signature in papillary thyroid cancer with lymph node metastasis.
Ab Mutalib NS; Othman SN; Mohamad Yusof A; Abdullah Suhaimi SN; Muhammad R; Jamal R
PeerJ; 2016; 4():e2119. PubMed ID: 27350898
[TBL] [Abstract][Full Text] [Related]
7. Identification of circulating microRNA signatures as potential noninvasive biomarkers for prediction and prognosis of lymph node metastasis in gastric cancer.
Jiang X; Wang W; Yang Y; Du L; Yang X; Wang L; Zheng G; Duan W; Wang R; Zhang X; Wang L; Chen X; Wang C
Oncotarget; 2017 Sep; 8(39):65132-65142. PubMed ID: 29029418
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA Expression Profiling on Paired Primary and Lymph Node Metastatic Breast Cancer Revealed Distinct microRNA Profile Associated With LNM.
Elango R; Alsaleh KA; Vishnubalaji R; Manikandan M; Ali AM; Abd El-Aziz N; Altheyab A; Al-Rikabi A; Alfayez M; Aldahmash A; Alajez NM
Front Oncol; 2020; 10():756. PubMed ID: 32509578
[TBL] [Abstract][Full Text] [Related]
9. A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis.
Yang G; Zhang Y; Yang J
Front Oncol; 2019; 9():1207. PubMed ID: 31799184
[TBL] [Abstract][Full Text] [Related]
10. MiRNAs in endometrioid endometrial cancer metastatic loci derived from positive lymph nodes.
Wilczynski M; Senderowska D; Krawczyk T; Szymanska B; Malinowski A
Acta Obstet Gynecol Scand; 2020 Aug; 99(8):1085-1091. PubMed ID: 32100871
[TBL] [Abstract][Full Text] [Related]
11. Identification of endometrioid endometrial carcinoma-associated microRNAs in tissue and plasma.
Tsukamoto O; Miura K; Mishima H; Abe S; Kaneuchi M; Higashijima A; Miura S; Kinoshita A; Yoshiura K; Masuzaki H
Gynecol Oncol; 2014 Mar; 132(3):715-21. PubMed ID: 24491411
[TBL] [Abstract][Full Text] [Related]
12. Construction of a Nine-MicroRNA-Based Signature to Predict the Overall Survival of Esophageal Cancer Patients.
Zhang X; He Y; Gu H; Liu Z; Li B; Yang Y; Hao J; Hua R
Front Genet; 2021; 12():670405. PubMed ID: 34093662
[TBL] [Abstract][Full Text] [Related]
13. Integrating microRNA expression, miRNA-mRNA regulation network and signal pathway: a novel strategy for lung cancer biomarker discovery.
Nie R; Niu W; Tang T; Zhang J; Zhang X
PeerJ; 2021; 9():e12369. PubMed ID: 34754623
[TBL] [Abstract][Full Text] [Related]
14. Identification of Prognostic miRNA Signature and Lymph Node Metastasis-Related Key Genes in Cervical Cancer.
Chen S; Gao C; Wu Y; Huang Z
Front Pharmacol; 2020; 11():544. PubMed ID: 32457603
[TBL] [Abstract][Full Text] [Related]
15. Identification and external validation of a novel miRNA signature for lymph node metastasis prediction in submucosal-invasive gastric cancer patients.
Ma M; Lu S; Liu Y; Kong P; Long Z; Wan P; Zhang Y; Wang Y; Xu D
Cancer Med; 2019 Oct; 8(14):6315-6325. PubMed ID: 31486298
[TBL] [Abstract][Full Text] [Related]
16. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
[TBL] [Abstract][Full Text] [Related]
17. miRNA-21 and miRNA-223 expression signature as a predictor for lymph node metastasis, distant metastasis and survival in kidney renal clear cell carcinoma.
Yu L; Xiang L; Feng J; Li B; Zhou Z; Li J; Lin Y; Lv Y; Zou D; Lei Z; Zhang J
J Cancer; 2018; 9(20):3651-3659. PubMed ID: 30405833
[No Abstract] [Full Text] [Related]
18. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel predictive model for lymph node metastasis in patients with endometrial endometrioid carcinoma.
Guo X; Lin C; Zhao J; Tang M
BMC Cancer; 2022 Dec; 22(1):1333. PubMed ID: 36539714
[TBL] [Abstract][Full Text] [Related]
20. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
Gene; 2019 May; 697():86-93. PubMed ID: 30779946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
